Avon Products Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: New York NY United States (1886)
Status: Acquired by International Minerals and Chemical Corporation (1986)

Organization Overview

First Clinical Trial
None
First Marketed Drug
1982
acetaminophen (tylenol)
First NDA Approval
1982
xenon xe-127
Last Known Activity
2022

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Avon Products, Inc.

Active Ingredients

Marketed Drugs (9)

Key: Avon Products (7) Acquired (2)

acetaminophen (tylenol) (1982)

butalbital (fiornal) (1985)

caffeine (1985)

diatrazoate meglumine (Renografin) (1984)

hydrocodone (hycodan) (1982)

imipramine (tofranil) (1984)

sodium bicarbonate (1985)

tartaric acid (1985 NDA)

xenon xe-127 (1982 NDA)

Drugs in Phase 4 Trials (17)

Key: Avon Products (0) Acquired (17)

acetaminophen (tylenol) (35 trials)

corticotropin (acthar) (57 trials)

gadoversetamide (optimark) (1 trial)

hydromorphone (diladid) (7 trials)

in111-octreoscan (2 trials)

iodixanol (visipaque) (1 trial)

ioversol (optiray) (1 trial)

methoxsalen (12 trials)

methylprednisolone (medrol) (5 trials)

morphine (3 trials)

nitric oxide (inomax) (40 trials)

nitrogen (11 trials)

nitrous oxide (1 trial)

oxycodone (oxycontin) (11 trials)

prednisone (meticorten) (3 trials)

sodium chloride (5 trials)

tacrolimus (prograf) (4 trials)

Drugs in Phase 3 Trials (13)

Key: Avon Products (0) Acquired (13)

baclofen (lioresal) (1 trial)

calfactant (infasurf) (1 trial)

chlorhexidine (hibitane) (1 trial)

cyclosporine (sandimmune) (2 trials)

endotoxin (2 trials)

gelatin (3 trials)

human fibrin (Tisseel) (4 trials)

hydrocodone (hycodan) (8 trials)

omiganan (2 trials)

ornithine (2 trials)

oxygen (4 trials)

povidone-iodine (betadine) (1 trial)

terlipressin (Terlivaz) (3 trials)

Drugs in Phase 2 Trials (7)

Key: Avon Products (0) Acquired (7)

carbon monoxide (1 trial)

diclofenac (voltaren) (3 trials)

etanercept (enbrel) (1 trial)

mycophenolate (CellCept) (1 trial)

rifaximin (xifaxan) (1 trial)

sodium sulfide (3 trials)

stem cells (1 trial)

Drugs in Phase 1 Trials (6)

Key: Avon Products (0) Acquired (6)

chlorpheniramine (ChlorTrimeton) (2 trials)

dexchlorpheniramine maleate (polaramine) (2 trials)

doxorubicin (Doxil) (1 trial)

expressgraft-c9t1 skin tissue (1 trial)

fentanyl (Innovar) (1 trial)

mnk-010 (1 trial)

Indications

Overview

  • Highest Phase: None
  • # of Trials: 190
  • # of Trial APIs: 43